Thyrocare Technologies Q4 Results
- BSE: 539871
- NSE: THYROCARE
- ISIN: INE594H01019
- Sector: Healthcare Facilities
BSE
400.40
-1.20 (-0.30%)
-1.20 (-0.30%)Volume6.37 K
Updated: Fri 13 Feb, 2026 | 15:25:09
NSE
403.10
1.20 (0.30%)
1.20 (0.30%)Volume2.21 L
Updated: Fri 13 Feb, 2026 | 15:40:16
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q4 Results Highlights
Quarter ended Mar 25
Note: Comparison is on QoQ basis
Quarterly - Thyrocare Technologies Q4 Results
*All figures in crores except per share values
| Fiscal Period | Mar 25 | Dec 25 | QoQ Comp | Mar 24 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 143.24 | 165.49 | 1.41% | 132.54 | 8.07% |
| Depreciation/ Amortization | 13.77 | 21.63 | -19.28% | 13.06 | 5.44% |
| Operating Income | 43.92 | 30.04 | 78.03% | 21.71 | 102.30% |
| Net Income | 21.69 | 29.01 | 13.50% | 17.78 | 21.99% |
| Other Operating Expenses Total | 45.27 | 54.74 | 3.03% | 37.51 | 20.69% |
| Net Income Before Taxes | 47.18 | 35.39 | 68.98% | 22.91 | 105.94% |
| Total Revenue | 187.16 | 195.53 | 12.80% | 154.25 | 21.34% |
| Selling/ General/ Admin Expenses Total | 34.72 | 35.76 | -1.05% | 35.40 | -1.92% |
| Diluted Normalized EPS | 1.44 | 2.11 | 21.09% | 1.20 | 19.53% |